374Water Q2 net loss narrows 41% to $2.7 million; revenue rises 280% to $2.26 million
Reuters2026/08/14 20:13- 374Water posted Q2 net loss of USD 2.7 million, narrowing 41% from the year-earlier quarter.
- Revenue more than doubled to USD 2.26 million, up 280% year over year.
- Operating loss narrowed 65% to USD 1.62 million; other expenses rose to USD 1.07 million.
- Revenue growth was driven by USD 2 million recognized on the OC San contract after meeting a factory acceptance test.
- Management flagged substantial doubt about going concern; cash was USD 1.78 million at June 30, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)
A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.
Crypto prices
More
